Skip to main content
. 2020 Apr 8;15(4):e0218880. doi: 10.1371/journal.pone.0218880

Fig 3. Cytokines and Chemokines Compared between SCD Patients (treated or not treated with HU) and non-SCD Controls.

Fig 3

Biomarkers tested are grouped into anti-inflammatory (AI), chemoattractant (CA), coagulation (CO), growth factor (GF) and pro-inflammatory (PI) functional categories. Relative increases in concentration are shown in red and decreases in blue. * significantly different between SCD patients and non-SCD controls (p<0.05 after FDR correction).